Showing results (21-30 of 1,681) with videos related to
Sort By:
Pageof 169
Cancer Cell|July 16, 2014
Promising rationally derived combination therapy with PI3K and CDK4/6 inhibitorsTaru Muranen, Funda Meric-Bernstam, Gordon B MillsCell Reports. Medicine|April 8, 2026
Antibody-drug conjugates in breast cancer: Progress and future directionsAlexandra Bili Newman, Senthil Damodaran, Funda Meric-BernstamMolecular Oncology|July 11, 2015
Hepatocellular carcinoma: Where there is unmet needManojkumar Bupathi, Ahmed Kaseb, Funda Meric-Bernstam, et al.Molecular Cancer|September 26, 2009
The rapamycin-regulated gene expression signature determines prognosis for breast cancerArgun Akcakanat, Li Zhang, Spiridon Tsavachidis, et al.Biochemical and Biophysical Research Communications|August 21, 2007
Rapamycin regulates the phosphorylation of rictorArgun Akcakanat, Gopal Singh, Mien-Chie Hung, et al.Surgical Oncology Clinics of North America|September 10, 2013
Targeting the PI3-kinase/Akt/mTOR signaling pathwayBurhan Hassan, Argun Akcakanat, Ashley M Holder, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2013
Building a personalized medicine infrastructure at a major cancer centerFunda Meric-Bernstam, Carol Farhangfar, John Mendelsohn, et al.Cancer Journal (Sudbury, Mass.)|November 16, 2022
Recent Advances in the Development of Antibody-Drug Conjugates in Urothelial CancerOmar Alhalabi, Lina Altameemi, Matthew T Campbell, et al.Studies in Health Technology and Informatics|October 4, 2007
Currency of online breast cancer informationFunda Meric-Bernstam, Muhammad Walji, Smitha Sagaram, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2020
State-of-the-Art Strategies for Targeting RET-Dependent CancersVivek Subbiah, Dong Yang, Vamsidhar Velcheti, et al.Pageof 169